Litcius/Paper detail

Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy

Laura Pala, Fabio Conforti, Aron Goldhirsch

2020The Lancet Oncology15 citationsDOI

Topics & Concepts

MedicineMetastatic breast cancerBreast cancerOncologyInternal medicinePalbociclibCancerSubgroup analysisLetrozoleMeta-analysisTamoxifenAdvanced Breast Cancer TherapiesBRCA gene mutations in cancerCancer Genomics and Diagnostics
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy | Litcius